These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 32853464)

  • 1. Intratumor heterogeneity: A new perspective on colorectal cancer research.
    Zheng Z; Yu T; Zhao X; Gao X; Zhao Y; Liu G
    Cancer Med; 2020 Oct; 9(20):7637-7645. PubMed ID: 32853464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of genetic intratumor heterogeneity in colorectal cancer and matching patient-derived spheroid cultures.
    Árnadóttir SS; Jeppesen M; Lamy P; Bramsen JB; Nordentoft I; Knudsen M; Vang S; Madsen MR; Thastrup O; Thastrup J; L Andersen C
    Mol Oncol; 2018 Jan; 12(1):132-147. PubMed ID: 29130628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding intratumor heterogeneity by combining genome analysis and mathematical modeling.
    Niida A; Nagayama S; Miyano S; Mimori K
    Cancer Sci; 2018 Apr; 109(4):884-892. PubMed ID: 29352488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival.
    Morris LG; Riaz N; Desrichard A; Şenbabaoğlu Y; Hakimi AA; Makarov V; Reis-Filho JS; Chan TA
    Oncotarget; 2016 Mar; 7(9):10051-63. PubMed ID: 26840267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DITHER: an algorithm for Defining IntraTumor Heterogeneity based on EntRopy.
    Li L; Chen C; Wang X
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34096997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratumor heterogeneity: evolution through space and time.
    Swanton C
    Cancer Res; 2012 Oct; 72(19):4875-82. PubMed ID: 23002210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-regional sequencing reveals intratumor heterogeneity and positive selection of somatic mtDNA mutations in hepatocellular carcinoma and colorectal cancer.
    Li X; Guo X; Li D; Du X; Yin C; Chen C; Fang W; Bian Z; Zhang J; Li B; Yang H; Xing J
    Int J Cancer; 2018 Sep; 143(5):1143-1152. PubMed ID: 29569724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral tumor heterogeneity, its implications for patient monitoring and designing anti-cancer strategies.
    Mishra R
    Pathol Res Pract; 2024 Jan; 253():154953. PubMed ID: 38039738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph Node Metastases in Colon Cancer Are Polyclonal.
    Ulintz PJ; Greenson JK; Wu R; Fearon ER; Hardiman KM
    Clin Cancer Res; 2018 May; 24(9):2214-2224. PubMed ID: 29203589
    [No Abstract]   [Full Text] [Related]  

  • 10. Many private mutations originate from the first few divisions of a human colorectal adenoma.
    Kang H; Salomon MP; Sottoriva A; Zhao J; Toy M; Press MF; Curtis C; Marjoram P; Siegmund K; Shibata D
    J Pathol; 2015 Nov; 237(3):355-62. PubMed ID: 26119426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer evolution and heterogeneity.
    Mimori K; Saito T; Niida A; Miyano S
    Ann Gastroenterol Surg; 2018 Sep; 2(5):332-338. PubMed ID: 30238073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pan-cancer analysis of intratumor heterogeneity associated with patient prognosis using multidimensional measures.
    Kikutake C; Yoshihara M; Sato T; Saito D; Suyama M
    Oncotarget; 2018 Dec; 9(102):37689-37699. PubMed ID: 30701024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiregion Genomic Analysis of Serially Transplanted Patient-derived Xenograft Tumors.
    Sato K; Niida A; Masuda T; Shimizu D; Tobo T; Kuroda Y; Eguchi H; Nakagawa T; Suzuki Y; Mimori K
    Cancer Genomics Proteomics; 2019; 16(1):21-27. PubMed ID: 30587497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SpliceHetero: An information theoretic approach for measuring spliceomic intratumor heterogeneity from bulk tumor RNA-seq.
    Kim M; Lee S; Lim S; Kim S
    PLoS One; 2019; 14(10):e0223520. PubMed ID: 31644551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting intratumor heterogeneity suppresses colorectal cancer chemoresistance and metastasis.
    Chao S; Zhang F; Yan H; Wang L; Zhang L; Wang Z; Xue R; Wang L; Wu Z; Jiang B; Shi G; Xue Y; Du J; Bu P
    EMBO Rep; 2023 Aug; 24(8):e56416. PubMed ID: 37338390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimal barriers to invasion during human colorectal tumor growth.
    Ryser MD; Mallo D; Hall A; Hardman T; King LM; Tatishchev S; Sorribes IC; Maley CC; Marks JR; Hwang ES; Shibata D
    Nat Commun; 2020 Mar; 11(1):1280. PubMed ID: 32152322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatial and temporal clonal evolution of intrahepatic cholangiocarcinoma.
    Dong LQ; Shi Y; Ma LJ; Yang LX; Wang XY; Zhang S; Wang ZC; Duan M; Zhang Z; Liu LZ; Zheng BH; Ding ZB; Ke AW; Gao DM; Yuan K; Zhou J; Fan J; Xi R; Gao Q
    J Hepatol; 2018 Jul; 69(1):89-98. PubMed ID: 29551704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Turning the headlights on novel cancer biomarkers: Inspection of mechanics underlying intratumor heterogeneity.
    McBride M; Rida PC; Aneja R
    Mol Aspects Med; 2015 Nov; 45():3-13. PubMed ID: 26024970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subclonal Genomic Architectures of Primary and Metastatic Colorectal Cancer Based on Intratumoral Genetic Heterogeneity.
    Kim TM; Jung SH; An CH; Lee SH; Baek IP; Kim MS; Park SW; Rhee JK; Lee SH; Chung YJ
    Clin Cancer Res; 2015 Oct; 21(19):4461-72. PubMed ID: 25979483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratumor heterogeneity: finding the needle in a haystack for cancer treatment.
    Camps J; Ried T; Castells A
    Gastroenterology; 2013 Jul; 145(1):242-244. PubMed ID: 23726878
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.